The lung is one target organ to which solid tumors frequently metastasize. Given the systemic adverse effects of currently available treatments, developing effective strategies of drug/gene delivery directly to the lungs is therefore needed. Aerosol delivery is a noninvasive gene transfer approach to target the airways. Here, we sought to evaluate the potential to deliver a fractalkine (FKN)-encoding plasmid formulated with the tetrafunctional amphiphilic block copolymer 704 through aerosolization in two models of pulmonary metastases. FKN is a chemokine recently described as a good candidate to stimulate a strong antitumor immune response in various forms of cancers. Here, we have assessed the effect of single and repeated aerosolizations of FKN-encoding plasmid formulated with 704 on the development of experimental lung metastases of mouse colon carcinoma and osteosarcoma. For this purpose, we have designed FKN-Fc sequences encoding an optimized version of the chemokine. Repeated intratracheal administrations of 704/FKN-Fc markedly inhibited growth of experimental lung metastases of CT-26 and K7M2 cells. Our results showed that tetrafunctional amphiphilic block copolymer 704 is a highly efficient synthetic vector for mediating local and safe gene transfer into the lung. In addition, FKN-Fc gene therapy of pulmonary nodules may provide a promising immunotherapeutic approach.
Introduction
Common cancers that metastasize to the lung include breast, colon, prostate and bladder cancer, as well as neuroblastoma and sarcoma. 1 Lung metastasis is usually a fatal complication and remains the leading cause of cancer-related deaths. Curative surgery is only possible for the very few patients diagnosed in the early stage and systemic chemotherapy remains therefore the currently available therapy. However, drugs delivered systemically, which need to be given at high dose to compensate for the degradation in the circulation or in the gastrointestinal tract, induce adverse side effects on healthy organs. Developing effective strategies of drug delivery directly to the lungs is therefore needed to enhance local drug concentration, therapeutic potential and consequently greater health benefit. Chemokines, first identified as important chemotactic factors in the recruitment of leukocytes, are attractive candidates for improving the efficacy of cancer immunotherapy. [2] [3] [4] [5] In this context, fractalkine (CX3CL1) clearly appears as a good candidate for immunotherapy given its ability to recruit and activate immune cells to elicit an antitumor immune response. High expression of fractalkine in association with an increased density of tumor-infiltrating lymphocytes was found to be a marker of better prognosis in colorectal cancer patients. 6 In the same vein, Mlecnik et al. 7 reported that CX3CL1 chemokine attracts a subset of antitumor T cells with a specific intratumoral T-cell receptor repertoire correlated with the survival of the colorectal cancer patient. In the context of chemokinetransduced tumor cells, the overexpression of fractalkine in various experimental tumor models has been shown to promote a tumor-suppressive activity by improving the recruitment of distinct leukocytes depending on the tumor type. [8] [9] [10] [11] [12] [13] [14] Of interest, our group has demonstrated the T-cell-mediated immunotherapeutic potential of constitutive fractalkine expression by colon carcinoma cells. 13 More recently, mesenchymal stem cells have been used to deliver fractalkine into lung metastases of C26, Lewis lung carcinoma or B16F10 tumor mice, and resulted in a strong antitumoral effect and prolonged survival in mice. 11, 15 Although cancer therapies using mesenchymal stem cells as gene carrier in humans are theoretically attractive, several issues including their tumor-promoting effects still raise potential risks in clinical applications. 16 As gene carriers have a pivotal role in cancer gene therapy, more attention must be paid to the vectors used in developing an optimal delivery system according to the therapeutic aims, the gene of interest and the tumor characteristics. Beside the route of administration, the nature of the vector itself is of importance. 17 Indeed, direct intratracheal administration of non-viral vectors is thought to circumvent concerns raised by immunogenicity and safety issues of viral vectors, while offering the potential for repeated delivery and large-scale production. 18, 19 In this regard, a novel system for gene delivery to the lung was developed. 20 Aerosolized delivery of DNA formulated with non-ionic amphiphilic block copolymers was found to increase and prolong gene expression to the lung for several days with a lesser proinflammatory activity when compared to polyethyleneimine (PEI), so far proven the most potent non-viral vectors. The particles formed by non-ionic polymers and DNA are, however, ill-defined and exhibit complex morphologies not suitable for an immediate lung gene therapy. Consequently, new synthetic vectors consisting of four polyethyleneoxide/polypropylenoxide blocks centered on an ethylenediamine moiety have been reported for efficient in vivo gene transfer in skeletal and heart muscles. 21 This novel class of synthetic vectors combining the properties of cationic vectors and those of non-ionic amphiphilic polymer therefore seemed to be a good candidate for a non-viral strategy to improve gene transfer into the lungs. This study was carried out to fulfill two specific aims. First, we aimed at investigating whether these new vectors could be used for efficient local intratracheal gene delivery into mouse lung. Also, we sought to evaluate the therapeutic potential of fractalkine gene transfer against established lung nodules in mouse colon carcinoma and osteosarcoma models.
Materials and methods

Expression vector constructs
Eukaryotic expression vectors encoding the different forms of murine FKN fused to the coding sequence of the constant portion (Fc) of a mouse immunoglobulin G2a (IgG2a) were constructed in pFuse-mIgG2a (Invivogen, San Diego, CA). The soluble FKN-muc form of the chemokine was obtained by deletion of the region encoding the transmembrane and cytoplasmic domains as described previously (pFKN-muc). 13 The FKN variant restricted to the secreted chemokine domain (FKN) was generated through truncation of the cDNA upstream of the region encoding the mucin stalk. The plasmid pFc identical to pFuse-mIgG2a (Invivogen), in which a signal peptide sequence was inserted upstream of the mIgG2a sequence, was generated for the analysis of secreted mIgG2a specific effects. The empty plasmid pFuse lacking the IgG2a coding sequence was generated and used as a control vector. All constructs were verified by sequencing.
The plasmids pCMV-luc, 22 pCMV-LacZ (Clontech, Mountain Views, CA, USA) and pCIK-chloramphenicol acetyl transferase (CAT) (a generous gift from D Gill, Oxford, UK) contained luciferase, b-galactosidase and the CAT reporter genes controlled by the human cytomegalovirus immediate-early gene promoter. The plasmids were amplified and purified from recombinant Escherichia coli by means of Endofree plasmid purification columns (Qiagen, Courtaboeuf, France), and is thus presumed to contain negligible amounts of endotoxin (o0.1 endotoxin units/mg plasmids).
Cell transfection
To assess the secretion of the fusion proteins encoded by the various DNA constructs, transient transfection of HeLa cells with the empty plasmid (pFuse) and the three expression vectors (pFc, pFKN-Fc, pFKN-muc-Fc) was performed according to AMAXA's protocol (AMAXA Biosystems, Gaithersburg, MD, USA). Culture supernatants were harvested after 24 h and proteins were immunoprecipitated with protein A sepharose before being subjected to sodium dodecyl sulfate-polyacryalmide gel electrophoresis under unreduced conditions to preserve the disulfide-bonded dimer forms, western blotted with a goat biotinylated anti-mouse fractalkine monoclonal antibody (R&D Systems, Lille, France) and reprobed using goat anti-mouse Ig antibodies (Dakocytomation, Trappes, France). Detection was carried out by streptavidin conjugated to horseradish peroxidase (R&D systems). Bands were visualized by chemiluminescenceenhanced reaction (Amersham, Les Ulis, France).
In vitro chemotaxis assay Natural killer (NK) cells isolated from mouse spleens using Miltenyi separation columns (Miltenyi, Biotec, Paris, France) were resuspended in Roswell Park Memorial Institute 1640 medium containing 0.5% fetal bovine serum and loaded into the upper well of a transwell chamber (Costar, Cambridge, MA). The lower wells were filled with 0.6 ml of supernatants of HeLa cells transfected either with the empty plasmid (pFuse) or with one of the three expression vectors (pFc, pFKN-Fc, pFKN-muc-Fc), which were harvested after 24 h culture. The cells that had migrated through the polycarbonate membrane after 4 h were harvested from the lower chamber and counted under a microscope. The assay was performed in triplicate and the results expressed as the mean±s.e.m.
Preparation of DNA/polymers formulation Lutrol and tetrafunctional block copolymers 304, 704 and 904 were gifts from BASF (Mount Olive, NJ, USA) and In-Cell-Art (Nantes, France), respectively. Stock solutions were prepared at 20% (w v À1 ) in water and stored at 4 1C. Formulations of DNA with Lutrol or tetrafunctional block copolymers were prepared by equivolumetric mixing of Lutrol or tetrafunctional block copolymers at various concentrations in water with plasmid DNA FKN-Fc/704 aerosolization to tumor lungs P Richard-Fiardo et al solution at the desired concentration as described by McIlroy et al. 23 Complexes of poly(ethyleneimine) (25 kDa) PEI/DNA were prepared as described previously 24 in Hepes 10 mM, pH 7.4. Complexes were administrated at a PEI/ DNA charge ratios ( þ /À) of 2.
Animal procedures
Female Swiss were obtained at 8 weeks of age from Janvier (Le Genest Saint Isle, France).
At indicated time points, mice were anesthetized with ketamine/xylazine (70 and 15 mg kg À1 , respectively) and intracheally instillated or sprayed as already described. 20 For the induction of pulmonary nodules, CT26 cells (3 Â 10 4 ) and K7M2 cells (7.5 Â 10 5 ) were delivered by intravenous tail injection into syngeneic BALB/c mice, 6-8 weeks old and purchased from Harlan (Gannat, France). At 28 days after tumor cell injection, mice were killed and subjected to post-mortem examinations by a veterinary pathologist. Lungs were inflated and injected through tracheal cannulation either with 10% neutralbuffered formalin before being processed for routine histology or with 7% India Ink dye that reveals white tumor nodules against a black lung background. The extent of tumor development in the lungs was assessed by recording the number and the volume of all tumor nodules (cumulative volume) visible on the pleural surface. Tumor volume of each nodule was measured with calipers in the two perpendicular axes (a and b) and calculated according to the formula ab2p/6. All of the procedures involving laboratory animals and their care were conducted in accordance with institutional guidelines under veterinary supervision.
Gene and protein expression analysis Total RNA from mouse tumor-bearing lung tissues was extracted using RNeasy kit (Qiagen) and reverse transcribed into cDNA using the Superscript III enzyme (Invitrogen, Carlsbad, CA, USA). To assess FKN-Fc mRNA expression, cDNA was subjected to polymerase chain reaction using upstream (5 0 -GTCTCTAGGGTCT GAGGAGA-3 0 ) and downstream (5 0 -CCCGGAGAGT ACTGTTGTAA-3 0 ) primers of FKN-Fc and Taq polymerase.
Mouse lungs were dissected and quantified for CAT expression as described by Desigaux et al. 20 Bronchoalveolar lavage fluid was collected after washing three times the lungs with 500 ml of sterile phosphate-buffered saline containing a protease inhibitor cocktail (Roche Diagnostics, Meyland, France). The bronchoalveolar lavage fluid was centrifuged (10 000 g, 5 min, 4 1C), and the supernatants were used for protein analysis. Metastatic mouse lungs were dissected, frozen in liquid nitrogen and homogenized in 1 ml of lysis buffer supplemented with a protease inhibitor cocktail (Roche Diagnostics). After centrifugation at 10 000 g for 5 min, proteins in the supernatant were immunoprecipitated with protein A sepharose before being subjected to sodium dodecyl sulfate-polyacryalmide gel electrophoresis and western blotting as described above.
Histochemistry, histology and interleukin-6 assay After killing the animals, their lungs were dissected, paraffin embedded and cut into 8-mm-thick sections. Immunostaining of CAT was performed with a rabbit anti-mouse CAT antibody (Sigma, Saint Quentin Fallavier, France), followed by incubation with goat biotinylated anti-rabbit polyclonal antibodies (Sigma). After washing, bound antibodies were revealed by avidin-biotin complex immunoperoxidase method (Dakocytomation, Trappes, France). The 3,3 0 -diaminobenzidine-stained sections were counterstained with Harris hematoxylin (Sigma). b-Galactosidase staining and interleukin-6 (IL-6) levels were analyzed as already described. 20 
Statistical analysis
Statistical comparisons were performed using the unpaired Student's t-test for in vitro experiments and statistical significance was set at Po0.05. In vivo comparisons of volume and number of tumor nodules between treated and control mice were performed using the nonparametric Mann-Whitney U-test. Owing to multiple comparisons, P-values were corrected by Bonferroni test and significance was set at Po0.0253, o0.0169, o0.0128, o0.0102 for 2, 3, 4 or 5 comparisons, respectively.
Results
Airway transfection using amphiphilic block copolymers Tetrafunctional amphiphilic block copolymers 304, 704 and 904 are branched block copolymers consisting of poly(ethyleneoxide) and poly(propyleneoxide) blocks fixed to an ethylenediamine positively charged. A CAT reporter plasmid was formulated with the different block copolymers and injected intratracheally. After 2 days, lungs were evaluated for reporter gene expression. Formulations containing 0.25% (w v
À1
) 704 increased the expression of CAT when compared with 904 and 304 ( Figure 1a ), which have been previously shown to improve the transfection efficiency in skeletal and cardiac muscles. 21, 23, 25 We also evaluated the transfection efficiency of PEI and Lutrol, which have been previously shown to improve the transfection efficiency in lungs. 22, 26 Figure 1b illustrates that 704/DNA complexes increased CAT expression compared with that obtained with the maximally effective doses of DNA complexed with Lutrol or PEI. Similar data were obtained with the luciferase reporter gene (data not shown). Further experiments were performed with 704 at the concentration of 0.25%. We next evaluated the influence of injected DNA amounts on transgene expression. Figure 1c shows that CAT expression increased when the injected amount of DNA was raised.
Kinetics of reporter gene expression with 704 and Lutrol
We next evaluated the time course of CAT expression after direct intratracheal instillation of 100 mg of plasmid DNA formulated with either 704 or Lutrol (Figure 1d ). Short kinetic showed that CAT activity was detectable 6 h FKN-Fc/704 aerosolization to tumor lungs P Richard-Fiardo et al after intratracheal instillation of 704/DNA, increased until day 2 post-injection and was stable for at least 3 days. With a longer kinetic, we observed that CAT expression was maximal at day 2 post-injection, and then declined to reach background levels on day 21 (data not shown). Results also showed that for each time point, CAT activity was higher with 704 than with Lutrol.
Delivery of 704/DNA complexes using a MicroSprayer The efficiency of aerosolized 704/DNA complexes was evaluated using a MicroSprayer. Figure 2a shows that intratracheal instillation of 100 mg of DNA formulated with 704 led to CAT activity higher than those obtained with the MicroSprayer. However, when Lutrol/DNA complexes were also aerosolized in the same experimental conditions via the MicroSprayer, the resulting CAT expression was clearly lower than that obtained with 704.
To determine where gene expression occurred after intratracheal administration or aerosolization of 704/ DNA complexes, we used a b-galactosidase-expressing plasmid (Figure 2b and c) . Lungs intratracheally injected with 704/DNA show a significant X-gal staining of an individual pulmonary lobe (Figure 2b) . On the contrary, lungs receiving aerosolized complexes led to a uniformly distributed X-gal staining of each lobe (Figure 2c 
Histopathological analysis and inflammatory response
As shown in Figure 2d , lungs of mice injected with 704/DNA complexes did not exhibit histopathological abnormalities as evidenced by the absence, in Harris hematoxylin-counterstained lung sections, of mononuclear infiltration in peribronchial zones as well as around pulmonary blood vessels and in the alveoli. We also measured the IL-6 levels in the serum and lungs at various time points after intratracheal instillation or microspraying of 704/DNA complexes. Figure 2e shows that the level of IL-6 in serum was increased 6 h after injection in both instillated and aerosolized solutions. The level of IL-6 then sharply decreased to reach background levels by day 1. In lungs injected with instilled or aerosolized solution of 704/DNA, IL-6 levels was increased after 6 h, but decreased sharply in mice aerosolized, and reached the background level by day 1 and stayed at this level for (FKN-muc) , which was previously shown to exert marked antitumor effects when constitutively expressed in colon carcinoma 13 and a shorter variant obtained through truncation of the mucin stalk cDNA sequence (FKN) (Figures 3a and b) . For increased protein half-life following intratracheal delivery, the cDNA sequence of each FKN variant was inserted into an eukaryotic expression vector (pFuse-mIgG2a) encoding the chemokine fused to the coding sequence of the constant portion (Fc) of a mouse IgG2a (Figures 3a and b) . To assess the contribution of the secreted mIgG2a to the antitumor activity of our FKN-Fc variants, an additional vector exclusively secreting the Fc portion was required. As the pFuse-mIgG2a vector allowed the expression but not the secretion of the Fc fragment, a construct (pFc) was generated by inserting a signal peptide sequence upstream of the mIgG2a sequence (Figures 3a and b) . Finally, the empty plasmid pFuse lacking the IgG2a coding sequence was generated and used as a control vector.
The secretion of the two mouse FKN-Fc fusion proteins in the culture supernatants of transiently transfected HeLa cells was assessed by western blot analysis (Figure 3c) . Supernatants from the pFKN-mucFc-and the pFKN-Fc-transfected cells both showed the secretion of FKN-Fc products as revealed using both a specific antibody directed against the extracellular chemokine domain and anti-mouse Ig antibodies (Figure 3c ). The FKN-Fc yielded a protein band of B70 kDa in its dimeric form, because this recombinant protein consists of two disulfide-bound polypeptide chains each containing one chemokine domain (B12 kDa) fused to constant fragment Fc of mIgG2a (B25 kDa) (Figure 3c) . Similarly, the FKN-muc-Fc was predominantly found as a dimer of B230 kDa owing to the presence of the mucin stalks, which was described as heavily glycosylated. However, a discrete band at B90 kDa likely corresponding to monomer FKN-muc-Fc was also detected (Figure 3c ). We also verified that the cells transfected with the pFc construct did secrete the Fc fragment of mouse IgG2a that was only detectable by western blotting with anti-Ig antibodies (Figure 3d ). This plasmid was therefore retained for further analysis of the secreted mIgG2a-specific effects in our approach of cancer gene therapy. Finally, and as expected, no bands were detected in the supernatant of HeLa cells transfected with the control empty vector pFuse (Figure 3d ).
NK cells migration induced by fractalkine
To confirm that the proteins secreted by the nucleofected HeLa cells were biologically active, we investigated the ability of the various culture supernatants to induce the migration of NK cells freshly isolated from mouse spleens. The results presented in Figure 3e show that both fusion proteins secreted by the pFKN-muc-Fc-and the pFKN-Fc-transfected cells enabled NK cells migration in vitro. However, we observed that the migratory response to the FKN-muc-Fc variant of the chemokine was significantly increased compared with that induced by the FKN-Fc protein (20.6 vs 3.9, P ¼ 0.0016). As a consequence, the plasmid encoding the mucin-rich variant of fractalkine was retained for further assessment of the therapeutic potential of intratracheal gene delivery into mouse lungs.
In vivo validation of transgene expression in tumor-bearing lungs
We assessed the efficiency of fractalkine gene transfer to tumor-bearing lungs (Figure 4) . BALB/c mice were thus injected intravenously with CT26 colon cancer cells before receiving, 7 days later, a tracheal administration of either pFuse (mock vector), pFc or pFKN-muc-Fc plasmids formulated with 0.25% 704. After 48 h, lungs were collected and evaluated for transgene expression at the mRNA level. Specific detection of FKN-muc-Fc transgene was clearly shown in the tumor-bearing lungs treated with pFKN-muc-Fc but, as expected, not in those of pFcand pFuse-injected mice (Figure 4a ). At 5 days after intratracheal administration of DNA formulated with 704, anti-FKN immunoblotting of both lung tissues and bronchoalveolar lavage fluids revealed two bands at B70 and B140 kDa, likely corresponding to monomer and dimer of FKN-muc-Fc (Figure 4b ), respectively. These results suggested that the de novo-synthesized FKN-mucFc was secreted not only in lung tissues, but also in the pulmonary airways. Besides, difference of molecular weight of FKN-muc-Fc observed between the in vitro ( Figure 3c ) and the in vivo (Figure 4b ) conditions could be explained by a different glycosylation status of mucin domain.
Protective effect of FKN-muc-Fc transgene expression on lung lesions of colon carcinoma
We evaluated the effect of single and repeated aerosolizations of FKN-muc-Fc-encoding plasmid formulated with 0.25% 704 on the development of pulmonary lesions of colon cancer (Figures 4 and 5) . Mice intravenously injected with colon carcinoma cells received either a single treatment with formulated DNA at day 7 ( Figure 4 ) or repeated intratracheal administrations at days 4 and 9 ( Figure 5 ). After being killed, the extent of tumor development in the lung was assessed by recording the number and cumulative volume of nodules visible on the pleural surface. As shown in Figure 4c , there was no difference in the overall tumor development within lungs between the untreated (CT26) and the control-vector (pFuse)-treated mice (P ¼ 0.09), indicating no measurable effect of formulated DNA aerosolization on the development of lung nodules (Figure 4c) . Therefore, the polymer/ pFuse vector formulation was retained as the control treatment for experiments with repeated gene deliveries. Single (Figure 4c ) as well as multiple (Figure 5b ) intratracheal microspraying of formulated pFc alone also did not lead to any significant change in the tumor load (Figure 5a ), it seemed more relevant to consider the cumulative volume of nodules to assess the extent of tumor development. Using this criter, we effectively found that two injections of pFKN-muc-Fc significantly reduced the extent of tumor development compared with pFuse ( Figure 5c ). Indeed, the average cumulative nodule volume was 98.8 ± 32.5 mm 3 in the formulated pFKN-muc-Fc-treated group compared with 243.5±45.4 mm 3 in the formulated pFuse control animals (P ¼ 0.008). Moreover, this antitumour activity seemed to be FKN specific as significant difference in the nodule cumulative volumes was observed between the formulated FKN-Fc/704 aerosolization to tumor lungs P Richard-Fiardo et al pFc-and pFKN-muc-Fc-injected groups (P ¼ 0.021). In addition, the protective action of FKN-muc-Fc was also associated with an improvement in the general health status of the mice as reflected by the monitoring of their body weight. Indeed, we noticed that the animals receiving the chimera clearly exhibited a better body weight compared with the other groups (Figure 5d ).
Protective effect of FKN-muc-Fc transgene expression on lung lesions of osteosarcoma We next examined the in vivo effects of fractalkine delivery in experimental mouse model of osteosarcoma lung metastases ( Figure 6 ). Mice intravenously injected with K7M2 cells received repeated intratracheal administrations of either pFuse, pFc or pFKN-muc-Fc, formulated with 0.25% 704 at days 4 and 9. After 1 month, lungs of tumor-bearing mice were dissected and the extent of tumor development in the lung was assessed by recording the number and cumulative volume of nodules visible on the pleural surface. As in the colon carcinoma experiments, pFuse vector formulation was retained as the control treatment, as no significant effect was noticed in the overall tumor development in response to aerosol administration of formulated pFuse plasmid in comparison to untreated group (Figures 6b and c) . In contrast, osteosarcoma-bearing mice injected with formulated pFKN-muc-Fc statistically developed fewer (P ¼ 0.003; Figure 6b ) and smaller (P ¼ 0.0003; Figure 6c ) nodules on the pleural surface than animals from pFuse group. If FKN by itself failed to significantly decrease the number of lung nodules (pFKN-muc-Fc group vs pFc group; Figure 6b ), in contrast, it statistically reduced their size as reflected by the cumulative volume of the both groups (112.6 ± 8.5 vs 291.4 ± 90.4 mm 3 , P ¼ 0.0026).
Discussion
A major challenge in gene therapy is the construction of vector systems that deliver genes to cells with a high degree of efficacy, but induce minimal tissue toxicity and anti-vector immunity. In this study, we have assessed whether tetrafunctional amphiphilic block copolymers, a novel class of synthetic vectors, could constitute a novel system for gene transfer to the airways. Recently, the tetrafunctional block copolymer 704 has already proven very attractive for its transfection efficiency in skeletal muscles, leading to high transgene expression eliciting strong humoral and cellular responses specific to the expressed antigen by gene transfer. 23 Here, we have evaluated the efficacy of several amphiphilic block copolymers to deliver genes within lung tissues in mice. ) were injected into the tail vein of BALB/c mice. After 7 days, mice were intratracheally microsprayed with either 100 mg pFuse, pFc, pFKN-muc or pFKN-muc-Fc plasmids formulated with 0.25% 704. CT26 group did not receive any plasmid formulation and corresponded to untreated mice. When being killed, the number of tumor nodules on the lung surface was counted macroscopically. Each dot represents the number of nodules per mouse. Horizontal bars indicate the mean value in each group (n ¼ 12 mice per group). The Mann-Whitney U-test with Bonferroni's correction was used for statistical analysis.
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Among the tetrafunctional block copolymers tested, 704 was the most efficient in lung gene transfer. We have also compared the efficiency of 704 with those of Lutrol and PEI. Interestingly, intratracheally injected 704/DNA complexes produced five-and eightfold higher levels of gene expression than did Lutrol/DNA and PEI/DNA polyplexes, respectively. Comparing delivery techniques of 704/DNA complexes, we found that instillation led to higher gene expression levels than aerosolization. Of importance, however, distinct patterns of gene expression within pulmonary tissues were clearly observed. Whereas gene reporter expression was found localized to an individual pulmonary lobe following instillation, gene delivery through aerosolization induced a uniform and consistent distribution of gene expression throughout the organ. In addition, numerous histological structures located along the delivery route were transfected following microspraying, such as the pneumocytes, the bronchial epithelium, the trachea, but gene expression was also detected within other tissues such as the smooth muscle located behind the bronchial epithelium and vascular epithelium. Given the fact that non-viral vectors, particularly highly positively charged PEI and cationic lipids, can cause significant inflammation in the lungs, we further analyzed lung tissues for inflammatory infiltrates, but failed to detect any histopathological abnormality in response to 704/DNA administrations. Also, despite the wider pattern of gene expression observed within the airways of aerosolized mice compared with those of instilled animals, we measured much less systemic inflammatory responses in the microsprayed mice. Altogether, the aerosol delivery of 704/DNA complexes via microspraying seemed to produce the most uniform expression pattern and to display only a mild, time-dependent inflammatory response suitable for repeated administrations. Therefore, aerosolized 704/DNA complexes were further used to deliver gene of therapeutic interest, in this study FKN, into tumor-bearing lungs of colon carcinoma where the transfer of native FKN with mesenchymal stem cell-and virus-based methods were reported to significantly reduce tumor growth. 15 Indeed, the ultimate aim of this area of research was for the development of a cellular therapy for humans and the literature was divided on the long-term impact that MSCs have on tumor growth with both growth stimulatory and inhibitory effects described, 27 as well as on the risk of using adenoviral vector. 28, 29 Non-viral methods could FKN-Fc/704 aerosolization to tumor lungs P Richard-Fiardo et al resolve such inconveniences and seemed to be good clinical options. In this study, we have chosen to deliver an FKN-Fc transgene that offers the advantage over native proteins, such as to prolong circulating half-life. As evidenced by chemotaxis experiments, FKN-Fc fusion protein kept the biological functions of the native chemokine moiety. FKN-Fc fusion protein was easily detectable 5 days after a single intratracheal administration of each 704-formulated DNA not only in lung tissues, but also in pulmonary airways. In parallel, antitumor activity of FKN-Fc transgene was already detectable with a single aerosolization and was intensified with repeated injections. In contrast, the native form of this chemokine lacking the Fc fragment failed to show any antitumor activity on pulmonary nodules of colon carcinoma, suggesting a possible role played by the Fc fragment in either potentiating antitumor action of fractalkine and/or prolonging its half-life. 10 Indeed, partially dependent on the level of gene transfer, the chemokine concentration at tumor site plays a critical role in inducing tumor regression. As the efficiencies of non-viral gene transfer methods are usually considered to be lower than those of cell-or viral-mediated methods, we can suppose that prolonged circulating half-life of FKN-Fc is required to compensate reduced efficiency of 704-mediated gene transfer.
Given that delivering the gene of FKN into tumorbearing lungs through 704-mediated gene delivery could provide antitumor benefit, we were intrigued to evaluate our strategy in pulmonary lesions from a cancer of distinct origin.
Lung metastases are the main cause of death in patients with osteosarcoma, and the therapeutic potential of FKN has never been evaluated on this pathology, which represents the most common primary bone tumor. Therefore, we next assessed the effect of 704-FKN-Fc aerosolization in mice bearing K7M2-derived lung nodules. Here again, our experiments highlighted the protective effect of FKN-Fc transgene on osteosarcoma lung lesions. Moreover, the Fc fragment was found to significantly reduce by itself the growth of osteosarcoma lung lesions, supporting the conclusion that Fc receptor engagement is a substantial contributing component of antitumor activity. Although the mechanisms by which fractalkine exerts its antitumor activity on osteosarcoma lung lesions have not been identified yet, we can suppose that innate immunity (via NK cells) and adaptive immunity (via CD8 þ T cells and/or dendritic cell) are likely to play a major role in mediating tumor regression of osteosarcoma lung metastasis as reported in colon carcinoma and in many other solid tumors development. [8] [9] [10] [11] 13, 30, 31 In addition to reinforcing this assumption, IL-12, which notably activates NK cells and facilitates the induction of cytotoxic and T helper type 1 T cells, [32] [33] [34] [35] was found to inhibit the development of osteosarcoma lung metastases.
Altogether, tetrafunctional block copolymer 704 appears as an excellent non-viral vector candidate for gene delivery to the lung. Indeed, 704-mediated gene transfer into lung proves to be an efficient and harmless method that can be easily and safely repeated so that FKN-Fc/704 aerosolization to tumor lungs P Richard-Fiardo et al sufficient levels of proteins of interest can be maintained within pulmonary tissues. Specifically, our data show induction of fractalkine in the tumor lung environment with tumor regression. Finally, we conclude that intratracheal aerosolization may be a valuable way to deliver FKN to the lung and serves as adjuvant therapy to surgery or systemic chemotherapy. Local therapy using 704/FKN-Fc may thus offer a promising approach to impair the development of lung metastases.
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